Bookmark
Forward
Explore Literature Results
Explore Clinical Trials Results
QuickView for NY- ESO- 1
Most Relevant Literature
- PLGA Nanoparticles Co-encapsulating NY-ESO-1 Peptides and IMM60 Induce Robust CD8 and CD4 T Cell and…
- Adjuvant NY-ESO-1 vaccine immunotherapy in high-risk resected melanoma: a retrospective cohort analy…
- Simultaneous noninvasive ultrasensitive detection of prostate specific antigen and lncRNA PCA3 using…
- Use of the MyProstateScore Test to Rule Out Clinically Significant Cancer: Validation of a Straightf…
- Fusion of NY-ESO-1 epitope with heat shock protein 70 enhances its induced immune responses and anti…
Most Relevant Clinical Trials
- T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expre…
- Safety Study of NY-ESO-1 Protein Vaccine to Treat Cancer Expressing NY-ESO-1
- NY-ESO-1-Specific T-cells in Treating Patients With Advanced NY-ESO-1-Expressing Sarcomas Receiving …
- Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally …
- Study of NY-ESO-1 ISCOMATRIX® in Patients With Measurable Stage III or IV Melanoma
